Pfizer CEO says proposed AstraZeneca bid wouldn't face antitrust problems
Pfizer Chief Execuitive Ian Read told UK politicians today that a proposed bid for AstraZeneca wouldn't face antitrust problems anywhere in the world. New York-based Pfizer is seeking to overcome concerns that...To view the full article, register now.
Already a subscriber? Click here to view full article